Challenging the Diagnosis: A Step-by-Step Guide to Seeking a Second Opinion for CJD

A diagnosis of Creutzfeldt-Jakob disease is among the most devastating words a neurologist can deliver. It is also, statistically, one of the most frequently incorrect. Studies examining CJD cases have found that a meaningful proportion of patients initially receive a different diagnosis—ranging from autoimmune encephalitis to rapidly progressing Alzheimer's disease to psychiatric conditions—before the correct identification is made. In a disease where the window of time is so narrow, diagnostic accuracy is not a bureaucratic formality. It is a matter of life, death, and the quality of whatever time remains.

Seeking a second opinion is not an act of distrust toward your physician. It is a medically sound, widely endorsed practice—and in the case of CJD, it may be the single most important step a family takes.

Why CJD Is So Frequently Misidentified

CJD belongs to a family of diseases called prion diseases, which are caused by misfolded proteins that progressively damage brain tissue. Because the disease is rare—affecting approximately one to two people per million annually in the United States—most general neurologists will encounter it only once or twice in an entire career, if at all. This unfamiliarity is not negligence; it is a statistical reality.

The symptoms of early CJD—cognitive decline, behavioral changes, gait disturbances, visual disturbances, and depression—overlap substantially with a wide range of more common conditions. Autoimmune encephalitis, Lewy body dementia, viral encephalitis, paraneoplastic syndromes, and metabolic encephalopathies can all produce clinical pictures that resemble early prion disease. Without access to specialized diagnostic tools and deep familiarity with CJD's specific progression pattern, even experienced neurologists can arrive at the wrong conclusion.

This is precisely why specialized centers exist—and why routing a suspected CJD case to one of them is so consequential.

Step One: Understand Your Right to a Second Opinion

In the United States, every patient has the legal and ethical right to seek an additional medical opinion at any time, for any reason. Your physician cannot prevent you from doing so, and a reputable physician will not discourage it. In fact, many neurologists actively welcome the involvement of a specialized center when CJD is on the differential diagnosis, recognizing the limits of their own exposure to the disease.

If you feel hesitant about raising the topic with your current doctor, consider framing it simply: "Given how rare this condition is, we would like to have our case reviewed by a center that focuses specifically on prion diseases. Can you help us facilitate that?" Most physicians will respond constructively.

Step Two: Gather and Organize Your Medical Records

Before any second-opinion consultation can occur, the reviewing specialist will need access to the full diagnostic picture. Under the Health Insurance Portability and Accountability Act (HIPAA), you have the right to request copies of all your medical records, and healthcare providers are generally required to fulfill that request within 30 days.

For a suspected CJD case, the records you should request include:

• All neuroimaging studies, including MRI scans with their original DICOM files (not just the printed report). DWI and FLAIR sequences are particularly important for CJD evaluation.
• Electroencephalogram (EEG) reports and, if possible, raw data files
• Cerebrospinal fluid (CSF) laboratory results, including 14-3-3 protein, total tau, and—if performed—real-time quaking-induced conversion (RT-QuIC) assay results
• Genetic testing results, if any have been conducted
• All clinical notes from neurology, psychiatry, and any other involved specialties
• A complete medication history

Organize these documents chronologically and, if possible, create a one-page summary of symptom onset, progression timeline, and diagnoses considered. This summary will help the reviewing specialist orient quickly and focus their attention on the most critical questions.

Step Three: Identify the Right Second-Opinion Resource

Not all second opinions carry equal weight in the context of CJD. A consultation with a general neurologist at a different community hospital may offer limited additional insight. What families need is access to a center or specialist with specific, deep expertise in prion diseases.

In the United States, several academic medical centers have established prion disease programs with dedicated diagnostic and research infrastructure. The National Prion Disease Pathology Surveillance Center (NPDPSC) at Case Western Reserve University in Cleveland is one of the foremost national resources and accepts referrals for diagnostic review. The University of California San Francisco (UCSF) Memory and Aging Center also maintains significant prion disease expertise.

The Newark CJD Center serves patients and families in the greater metropolitan area and beyond, offering specialized evaluation, access to the latest diagnostic protocols including RT-QuIC testing, and coordination with national surveillance and research networks. If you are located in New Jersey or the surrounding region, our center can serve as a primary point of contact for second-opinion consultations.

Step Four: Know What Questions to Ask

Arriving at a second-opinion consultation with prepared questions transforms a passive appointment into an active diagnostic partnership. Consider asking the following:

• Has RT-QuIC testing been performed on the cerebrospinal fluid? This assay, which detects misfolded prion proteins with high sensitivity and specificity, has become a cornerstone of CJD diagnosis and is not universally available. If it has not been done, ask whether the reviewing center can facilitate it.
• What is the differential diagnosis, and what evidence supports or argues against each possibility? A specialist should be able to walk you through the reasoning, not simply deliver a conclusion.
• Are there any additional diagnostic studies that could increase certainty? Brain biopsy, additional imaging sequences, or repeat lumbar puncture may be appropriate in some cases.
• Is there an identifiable genetic component? Familial CJD accounts for roughly 10–15% of cases and has implications for other family members. Genetic counseling may be warranted.
• What does the current evidence say about treatment or clinical trial eligibility? While there is currently no approved disease-modifying treatment for CJD, clinical research is active, and some patients may qualify for investigational protocols.

Step Five: Navigate Insurance and Logistics Proactively

The practical mechanics of seeking a second opinion—particularly across state lines or at an academic medical center—can feel overwhelming. A few steps can reduce friction significantly.

Contact your insurance provider before scheduling to confirm coverage for out-of-network consultations. Many insurers will authorize second opinions for rare or serious conditions, particularly when requested by your treating physician. Ask your current neurologist to write a formal referral letter; this can facilitate insurance approval and ensures the reviewing center receives a clinical summary directly from the treating team.

For families who face financial barriers, it is worth noting that the NPDPSC offers no-cost diagnostic services for confirmed or suspected CJD cases as part of its national surveillance mission. The Newark CJD Center's care coordinators can assist families in identifying financial assistance resources and navigating the referral process.

The Cost of Waiting

In most medical contexts, taking a few weeks to gather records and schedule a consultation carries minimal risk. In CJD, the timeline is unforgiving. If you suspect that a diagnosis may be incorrect—or simply want confirmation before committing to a care pathway—begin the second-opinion process immediately, in parallel with whatever current care is underway. These two tracks are not mutually exclusive.

Advocating for diagnostic clarity is not a sign of panic. It is the most rational response to a situation where accuracy determines everything that follows. The Newark CJD Center exists precisely to support families in that advocacy—because no one should face this disease without access to the best available diagnostic expertise.